Was the composite outcome specified in the original protocol?

BMJ (Online)

Volumn 345, Issue 7886, 2012, Pages

  Schroll, Jeppe ^a   Lundh, Andreas ^a  

^a Nordic Cochrane Centre   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPOSITE OUTCOME; EXPLORATORY RESEARCH; HEART FAILURE; HEART INFARCTION; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; INCIDENCE; ISCHEMIC HEART DISEASE; LETTER; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SAFETY;

FEMALE; HEART FAILURE; HORMONE REPLACEMENT THERAPY; HUMANS; MYOCARDIAL INFARCTION; NEOPLASMS;

EID: 84870663866     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8144     Document Type: Letter

References (5)

1. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012;345:e6409. (9 October.)
2. Johansen EM. [Hormones halve risk of cardiovascular disease among women in menopause.] Dagens Medicin 2012 October 19.
3. Schierbeck LL, Køber L, Beck Jensen JE. [Electronic response to Schierbeck LL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.] BMJ 2012. www.bmj.com/content/345/bmj.e6409/rr/612351.
4. Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sorensen OH. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 1999;31:207-19. (Pubitemid 29132822)
5. Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P, et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas 2000;36:181-93.